Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andriy Derkach

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
Blood Advances|February 24, 2026
Early Mortality with Bispecific Antibody Therapy in RRMM: An IMWG Immunotherapy Database Real-World AnalysisCarlyn Rose Tan, Saad Z Usmani, Andriy Derkach, et al.
Leukemia & Lymphoma|September 3, 2021
Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplantJan Philipp Bewersdorf, Andriy Derkach, Lohith Gowda, et al.
Blood Cancer Discovery|February 1, 2023
Molecular Evolution of Classic Hodgkin Lymphoma Revealed Through Whole-Genome Sequencing of Hodgkin and Reed Sternberg CellsFrancesco Maura, Bachisio Ziccheddu, Jenny Z Xiang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 2, 2022
Breast Cancer Risk in Women from Ghana Carrying Rare Germline Pathogenic MutationsThomas U Ahearn, Parichoy Pal Choudhury, Andriy Derkach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2024
Genomic Classification and Individualized Prognosis in Multiple MyelomaFrancesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2022
Sustained Minimal Residual Disease Negativity in Multiple Myeloma is Associated with Stool Butyrate and Healthier Plant-Based DietsUrvi A Shah, Kylee H Maclachlan, Andriy Derkach, et al.
JAMA Oncology|April 15, 2021
Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma: The MANHATTAN Nonrandomized Clinical TrialOla Landgren, Malin Hultcrantz, Benjamin Diamond, et al.
Blood Advances|October 31, 2025
Derivation and External Validation of a Venous Thromboembolism Risk Prediction Model in Asparaginase-Treated ALLDaniela R Anderson, Radhika Gangaraju, Wafik G Sedhom, et al.
American Journal of Hematology|October 17, 2022
Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemiaMaximilian Stahl, Andriy Derkach, Noushin Farnoud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2025
Genomics Define Malignant Transformation in Myeloma Precursor ConditionsFrancesco Maura, P Leif Bergsagel, Bachisio Ziccheddu, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
Blood Advances|February 24, 2026
Early Mortality with Bispecific Antibody Therapy in RRMM: An IMWG Immunotherapy Database Real-World AnalysisCarlyn Rose Tan, Saad Z Usmani, Andriy Derkach, et al.
Leukemia & Lymphoma|September 3, 2021
Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplantJan Philipp Bewersdorf, Andriy Derkach, Lohith Gowda, et al.
Blood Cancer Discovery|February 1, 2023
Molecular Evolution of Classic Hodgkin Lymphoma Revealed Through Whole-Genome Sequencing of Hodgkin and Reed Sternberg CellsFrancesco Maura, Bachisio Ziccheddu, Jenny Z Xiang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 2, 2022
Breast Cancer Risk in Women from Ghana Carrying Rare Germline Pathogenic MutationsThomas U Ahearn, Parichoy Pal Choudhury, Andriy Derkach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2024
Genomic Classification and Individualized Prognosis in Multiple MyelomaFrancesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2022
Sustained Minimal Residual Disease Negativity in Multiple Myeloma is Associated with Stool Butyrate and Healthier Plant-Based DietsUrvi A Shah, Kylee H Maclachlan, Andriy Derkach, et al.
JAMA Oncology|April 15, 2021
Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma: The MANHATTAN Nonrandomized Clinical TrialOla Landgren, Malin Hultcrantz, Benjamin Diamond, et al.
Blood Advances|October 31, 2025
Derivation and External Validation of a Venous Thromboembolism Risk Prediction Model in Asparaginase-Treated ALLDaniela R Anderson, Radhika Gangaraju, Wafik G Sedhom, et al.
American Journal of Hematology|October 17, 2022
Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemiaMaximilian Stahl, Andriy Derkach, Noushin Farnoud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2025
Genomics Define Malignant Transformation in Myeloma Precursor ConditionsFrancesco Maura, P Leif Bergsagel, Bachisio Ziccheddu, et al.
Pageof 14